Clinical Trial

Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Pain Management in Abdominal Surgery

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated December 30, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a multiple-center, randomized, double-blind, placebo-controlled study design evaluating the safety, efficacy, and pharmacokinetics (PK) parameter of HL-1186 tablet for postoperative pain management in abdominal surgery.
Trial Details
NCT Number NCT07311369
Lead Sponsor Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Conditions Moderate to Severe Acute Postoperative Pain
Enrollment 40 participants
Start Date 2025-12
Primary Completion 2026-02 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2025-12-30